MedPath

Effects of Iron administration on Auditory Brainstem Evoked Response in neonates at Risk of Latent Iron Deficiency

Not Applicable
Conditions
Condition 1: Neonatal hearing impairment. Condition 2: Iron deficiency anemia.
Sensorineural hearing loss, unspecified
anaemia
Registration Number
IRCT201709019568N18
Lead Sponsor
Maternal, Fetal & Neonatal Research Center, Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
80
Inclusion Criteria

Neonates with gestational ages>35 weeks and weight over 2,500 grshowing at least one of the risk factors for in utero Latent Iron Deficiency including maternal diabetes, maternal gestational hypertension, intrauterine growth restriction, and Serum Feritin levels between 11-75 ng/mL.
Exclusion criteria: Neonates with craniofacial anomalies, chromosome abnormalities, hemolytic diseases, history of infectious disease in the third trimester, clinical evidence of chorioamnionitis, 5-minute Apgar scores<5, evidence of TORCH infections, clinical or laboratory diagnosed sepsis, history of hospitalization in the NICU due to any medical issue.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eonatal hearing assessment. Timepoint: at birth and one month later. Method of measurement: ABR test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath